Both in Pharmaceuticals
Rezolute, Inc. Common Stock (NV) vs Assembly Biosciences
Over the past year RZLT returned −57.6% and ASMB returned −35.2%; their daily moves had a correlation of 0.06.
RZLT −57.6% ASMB −35.2%Growth of $1, one year, split-adjusted
| Metric | RZLT | ASMB |
|---|---|---|
| Price | $3.95 | $20.13 |
| Market cap | $382.1M | $409.9M |
| Today | −4.13% | −3.50% |
| 1 month | −2.9% | −12.4% |
| 6 months | +19.7% | −26.5% |
| Year to date | +67.4% | −40.8% |
| 1 year | −58.6% | −35.0% |
| Revenue growth (YoY) | — | +38.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −28.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.5× |
| Net cash | $107.8M | $320.4M |
| Dividend yield | — | — |
| Volatility (60d) | 59.6% | 63.4% |
| Short % of float | 22.5% | 28.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).